Tuesday, June 18, 2013 Last update: 12:04 AM
Company Tech News as it Breaks
GlycoMimetics, Inc.
News articles for GlycoMimetics, Inc.:
Friday, May 17, 2013
- Tech Council of Maryland Names GlycoMimetics CEO Rachel King as 2013 Executive of the YearGlycoMimetics, Inc. announced today that the Tech Council of Maryland (TCM) named Rachel K. King, GlycoMimetics Chief Executive Officer, as the winner ... read more
Tuesday, April 16, 2013
- GlycoMimetics Announces Top Line Results from Phase 2 Trial with GMI-1070 in Sickle Cell DiseaseGlycoMimetics, Inc. (GMI) today announced top line clinical results from a Phase 2 study of GMI-1070 in patients experiencing vaso-occlusive crisis (VOC) ... read more
Thursday, January 17, 2013
- GlycoMimetics Completes Enrollment in Phase 2 Sickle Cell Disease Study with Lead Drug Candidate GMI-1070GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company researching a new class of glycobiology-based therapies for a broad range of diseases, today announced ... read more